Lawrence R. Hoffman

Corporate Officer/Principal chez Pennsylvania State Bar Association

Profil

Lawrence R.
Hoffman currently works at Pennsylvania Institute of Certified Public Accountants, as Member, Pennsylvania State Bar Association, as Member, and Danforth Advisors LLC, as Member from 2021.
Mr. Hoffman also formerly worked at Jazz Pharmaceuticals (EUSA Pharma USA), Inc., as Chief Financial Officer & Vice President from 2000 to 2003, The Liposome Co., Inc., as Chief Financial Officer & Vice President from 1998 to 2000, LANXESS Sybron Chemicals, Inc., as Acting Chief Financial Officer & Secretary, Covalent Group, Inc., as Chief Financial Officer & Executive Vice President, SCYNEXIS, Inc., as Chief Financial Officer from 2021 to 2022, Aptiv Solutions, Inc. (Massachusetts), as Chief Financial & Accounting Officer in 2010, Encorium Group, Inc., as CFO, Secretary, EVP & General Counsel from 2004 to 2008, Sermonix Pharmaceuticals LLC, as Chief Financial Officer from 2018 to 2021, and Tenax Therapeutics, Inc., as Chief Financial & Accounting Officer in 2024.
Mr. Hoffman received his undergraduate degree from LaSalle University, graduate degree from Temple University (Pennsylvania), and graduate degree from Villanova University.

Postes actifs de Lawrence R. Hoffman

Sociétés	Poste	Début
Pennsylvania State Bar Association	Corporate Officer/Principal	07/01/2010
Pennsylvania Institute of Certified Public Accountants	Corporate Officer/Principal	07/01/2010
Danforth Advisors LLC	Corporate Officer/Principal	01/11/2021

Anciens postes connus de Lawrence R. Hoffman

Sociétés	Poste	Fin
TENAX THERAPEUTICS, INC.	Directeur Financier/CFO	02/12/2024
SCYNEXIS, INC.	Directeur Financier/CFO	24/10/2022
Sermonix Pharmaceuticals LLC	Directeur Financier/CFO	01/10/2021
Encorium Group, Inc.	Directeur Financier/CFO	02/05/2008
Covalent Group, Inc.	Directeur Financier/CFO	30/10/2006